fashion -WSS

fashion

author：knowledge 2025-09-06 04:30:43 - browse：3553

Illustration of three connected puzzle pieces, with a woman standing near the missing/empty puzzle piece space. -- first opinion coverage from STAT — Adobe

Women have always been underrepresented in medical research. A new study reveals that not much has changed, especially when it comes to tests of cardiovascular devices.

In a paper published in JAMA Internal Medicine on Monday, researchers found that the percentage of women represented in high-risk medical device trials did not increase from 2010 to 2020. Women generally made up just 33% of participants when the team reviewed 195 trials published from 2016 to 2022. The percentages varied between devices: Women made up 46% of participants in orthopedic trials, but 29% in cardiovascular studies.

The issue isn’t new. The government has made some strides in correcting earlier missteps, like the Food and Drug Administration telling researchers in 1977 to exclude women of reproductive potential from early clinical trials. But stakeholders think agencies like the FDA could do more to incentivize the enrollment of women.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Hospitals need to get ahead of regulations on climate change

focus

knowledge

WSS

Head of FDA's diagnostics center, who led through Covid, retires

Louisiana bill approved classifying abortion pills as controlled substances

The world needs the new pandemic treaty

J&J reports mixed data on next

Louisiana bill approved classifying abortion pills as controlled substances

The HPV vaccine prevents cancer in men, too. Why do so few people get it?

explore

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

entertainment

Dobbs anniversary: the lost opportunity of abortion as health care

FDA sets aggressive timeline for overhauling inspection procedures

Heart attack and stroke risk calculators need revising

Hospitals need to get ahead of regulations on climate change

Jerome Adams on the need for new antivirals for Covid

Sanofi to acquire U.S. biotech Inhibrx in $2.2 billion deal

In age of alternative facts, a scholarly course on calling out crap

Beyond aggravation: Constipation is an American epidemic

Trump demands the U.S. pay no more for drugs than other countries … again

Dana Farber says 6 studies to be retracted and 31 corrected

focus

What causes osteoarthritis? Researchers study link to brain protein

Medical students need to learn the potent medicine of empathy

Medical students need to learn the potent medicine of empathy

Sanofi to acquire U.S. biotech Inhibrx in $2.2 billion deal

Microsoft launches AI tool for clinical documentation through Epic

Immunocompromised patients offer clues on chronic Covid

entertainment

focus

knowledge

knowledge